BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 10148086)

  • 1. Pacemakers, defibrillators, and direct current cardioversion.
    Sgarbossa EB; Black IW; Maloney JD
    Curr Opin Cardiol; 1993 Jan; 8(1):27-38. PubMed ID: 10148086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Leadless pacemakers and subcutaneously implantable cardioverter defibrillators].
    Stellbrink C; Hansky B; Meyer Zu Vilsendorf D
    Internist (Berl); 2018 Oct; 59(10):999-1010. PubMed ID: 30105398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiac pacemakers and implantable cardioverter-defibrillators in the perioperative phase].
    Kemnitz J; Peters J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1993 Jun; 28(4):199-212. PubMed ID: 8353196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined automatic implantable cardioverter-defibrillator and pacemaker systems: implantation techniques and follow-up.
    Epstein AE; Kay GN; Plumb VJ; Shepard RB; Kirklin JK
    J Am Coll Cardiol; 1989 Jan; 13(1):121-31. PubMed ID: 2909559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitachycardia devices: realities and promises.
    Klein LS; Miles WM; Zipes DP
    J Am Coll Cardiol; 1991 Nov; 18(5):1349-62. PubMed ID: 1918713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implanted automatic defibrillators: effects of drugs and pacemakers.
    Singer I; Guarnieri T; Kupersmith J
    Pacing Clin Electrophysiol; 1988 Dec; 11(12):2250-62. PubMed ID: 2463613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of new pacemaker and defibrillator technology.
    Shepard RB; Epstein AE; Kay GN
    Adv Card Surg; 1994; 5():181-208. PubMed ID: 8118592
    [No Abstract]   [Full Text] [Related]  

  • 8. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
    Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
    J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing with pacemakers and implantable cardioverter defibrillators.
    Lampert R
    Circulation; 2013 Oct; 128(14):1576-85. PubMed ID: 24081953
    [No Abstract]   [Full Text] [Related]  

  • 10. Electrical cardioversion of patients with implanted pacemaker or cardioverter-defibrillator: results of a survey of german centers and systematic review of the literature.
    Lüker J; Sultan A; Plenge T; van den Bruck J; Heeger CH; Meyer S; Mischke K; Tilz RR; Vollmann D; Nölker G; Schäffer B; Willems S; Steven D
    Clin Res Cardiol; 2018 Mar; 107(3):249-258. PubMed ID: 29151182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current state of the art for use of pacemakers and defibrillators in patients with congenital cardiac malformations.
    Stephenson EA; Kaltman JR
    Cardiol Young; 2006 Sep; 16 Suppl 3():151-6. PubMed ID: 17378055
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitachycardia pacing and low-energy cardioversion for ventricular tachycardia termination: a clinical perspective.
    Estes NA; Haugh CJ; Wang PJ; Manolis AS
    Am Heart J; 1994 Apr; 127(4 Pt 2):1038-46. PubMed ID: 8160578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The current status of implantable automatic defibrillators].
    Villacastín JP
    Rev Esp Cardiol; 1997 Oct; 50(10):675-81. PubMed ID: 9417556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. PCD Investigator Group.
    J Am Coll Cardiol; 1994 Jun; 23(7):1521-30. PubMed ID: 8195508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac implantable electronic device and vascular access: Strategies to overcome problems.
    Kusztal M; Nowak K
    J Vasc Access; 2018 Nov; 19(6):521-527. PubMed ID: 29552930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with an implantable tiered therapy device incorporating antitachycardia pacing and cardioverter/defibrillator therapy.
    Mitchell JD; Lee R; Garan H; Ruskin JN; Torchiana DF; Vlahakes GJ
    J Thorac Cardiovasc Surg; 1993 Mar; 105(3):453-62; discussion 462-3. PubMed ID: 8445925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New generations of implantable pacemaker defibrillators for ventricular and atrial tachyarrhythmias.
    Saksena S; Prakash A; Madan N; Giorgberidze I; Munsif AN; Mathew P; Kaushik R; Krol RB
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():149-54. PubMed ID: 8734177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of pacemaker implantation in patients with transvenous (nonthoracotomy) implantable cardioverter defibrillators.
    Clemo HF; Ellenbogen KA; Belz MK; Wood MA; Stambler BS
    Pacing Clin Electrophysiol; 1994 Dec; 17(12 Pt 1):2285-91. PubMed ID: 7885936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.